A genomics-based classification of human lung tumors

The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM)

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    382 Citations (Scopus)

    Résumé

    We characterized genome alterations in 1255 clinically annotated lung tumors of all histological subgroups to identify genetically defined and clinically relevant subtypes. More than 55% of all cases had at least one oncogenic genome alteration potentially amenable to specific therapeutic intervention, including several personalized treatment approaches that are already in clinical evaluation. Marked differences in the patternof genomic alterations existed between and within histological subtypes, thus challenging the original histomorphological diagnosis. Immunohistochemical studies confirmed many of these reassigned subtypes. The reassignment eliminated almost all cases of large cell carcinomas, some of which had therapeutically relevant alterations. Prospective testing of our genomics-based diagnostic algorithm in 5145 lung cancer patients enabled a genome-based diagnosis in 3863 (75%) patients, confirmed the feasibility of rational reassignments of large cell lung cancer, and led to improvement in overall survival in patients with EGFRmutant or ALK-rearranged cancers. Thus, our findings provide support for broad implementation of genomebased diagnosis of lung cancer.

    langue originaleAnglais
    Numéro d'article209ra153
    journalScience Translational Medicine
    Volume5
    Numéro de publication209
    Les DOIs
    étatPublié - 30 oct. 2013

    Contient cette citation